Funding for this research was provided by:
SpeeDx Pty. Ltd.
Received: 2 May 2018
Accepted: 10 June 2019
First Online: 2 July 2019
Ethics approval and consent to participate
: The study was approved by the Human Research Ethics Committees (HRECs) of Children’s Health Queensland and The University of Queensland (HREC/13/QRCH/39). Informed consent was waived as per section 2.3.6 of the NHMRC national statement.
: Not applicable.
: This study was funded by SpeeDx Pty Ltd. MW, RW and LYT are employees of, and own stock or options in, SpeeDx Pty Ltd. DMW is a member of the editorial board of BMC Infectious Diseases.